SK Biopharmaceuticals Co., Ltd. (326030.KS)
KRW 103600.0
(-2.54%)
KRW 103600.0
(-2.54%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -95.82 Billion | -159.92 Billion | -92.87 Billion | -210.72 Billion | -81.33 Billion | -141.28 Billion |
| Net Income | -32.88 Billion | -139.43 Billion | 64.84 Billion | -247.41 Billion | -71.51 Billion | -138.09 Billion |
| Depreciation & Amortization | 15.31 Billion | 12.98 Billion | 11.64 Billion | 10.85 Billion | 6.5 Billion | 3.34 Billion |
| Deferred income taxes | -121.86 Billion | - | 45.85 Billion | - | - | - |
| Stock-based compensation | 3.23 Billion | 60.66 Million | 416.71 Million | - | - | - |
| Change in working capital | -77.26 Billion | -65.66 Billion | -69.71 Billion | 20.72 Billion | -6.87 Billion | -8.37 Billion |
| Other non-cash items | 117.63 Billion | 32.13 Billion | -145.91 Billion | 5.1 Billion | -9.43 Billion | 1.84 Billion |
| Investing Cash Flow | 225.27 Billion | -95.71 Billion | 258.97 Billion | -318.73 Billion | -39.46 Billion | 39.45 Billion |
| Investments in PPE | -3.24 Billion | -5.96 Billion | -5.99 Billion | -14.33 Billion | -14.04 Billion | -1.43 Billion |
| Acquisitions | 31.04 Billion | 4.23 Billion | 48.72 Billion | -3.31 Billion | 2.34 Billion | 1.58 Billion |
| Investment purchases | -106.41 Billion | -458.34 Billion | -174.03 Billion | -303.72 Billion | -29.01 Billion | -156.67 Thousand |
| Sales/Maturities of investments | 305 Billion | 364.41 Billion | 390.93 Billion | 42.12 Million | 472.44 Million | 37.1 Billion |
| Other Investing Activities | -1.1 Billion | -61.42 Million | -654.75 Million | 2.59 Billion | 779.74 Million | 2.2 Billion |
| Financing Cash Flow | 6.62 Billion | 134.91 Billion | -4.64 Billion | 540.9 Billion | 97.24 Billion | 149.96 Billion |
| Debt repayment | -5.57 Billion | -141.75 Billion | - | -100 Billion | -100 Billion | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 645.46 Billion | - | 149.96 Billion |
| Other Financing Activities | 6.62 Billion | 276.66 Billion | -4.64 Billion | -4.56 Billion | 197.24 Billion | - |
| Accounts receivables | -53.57 Billion | -12.38 Billion | -38.18 Billion | -11.24 Billion | -110.79 Million | 14.36 Billion |
| Accounts payables | -20.71 Billion | 6.96 Billion | 607.68 Million | 8.96 Billion | 110.79 Million | -24.47 Billion |
| Inventory | -13.7 Billion | -38.69 Billion | -29.45 Billion | -16.62 Billion | -6.73 Billion | - |
| Other working capital | 10.73 Billion | -21.54 Billion | -2.67 Billion | 39.63 Billion | -145.05 Million | 1.72 Billion |
| Cash at beginning of period | 104.05 Billion | 225.92 Billion | 59.33 Billion | 51.14 Billion | 74.29 Billion | 25.27 Billion |
| Cash at end of period | 239.7 Billion | 104.05 Billion | 225.92 Billion | 59.33 Billion | 51.14 Billion | 74.29 Billion |
| Capital Expenditure | -3.24 Billion | -5.96 Billion | -5.99 Billion | -14.33 Billion | -14.04 Billion | -1.43 Billion |
| Effect of forex changes on cash | -2.05 Billion | -1.14 Billion | 5.13 Billion | -3.25 Billion | 408.32 Million | 883.45 Million |
| Net cash flow / Change in cash | 135.64 Billion | -121.86 Billion | 166.58 Billion | 8.19 Billion | -23.15 Billion | 49.02 Billion |
| Free Cash Flow | -99.07 Billion | -165.88 Billion | -98.86 Billion | -225.06 Billion | -95.38 Billion | -142.71 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 28.13 Billion | 12.83 Billion | -32.88 Billion | 6.75 Billion | -18.41 Billion | -23.34 Billion |
| Depreciation & Amortization | 4.32 Billion | 4.36 Billion | 15.31 Billion | 4.49 Billion | 3.94 Billion | 3.5 Billion |
| Deferred income taxes | - | - | -121.86 Billion | -39.27 Billion | - | - |
| Stock-based compensation | - | 1.5 Billion | 3.23 Billion | 3.17 Billion | - | - |
| Change in working capital | -46.72 Billion | 3.61 Billion | -77.26 Billion | -44.89 Billion | -1.14 Billion | -3.72 Billion |
| Other non-cash items | 7.43 Billion | 4.38 Billion | 117.63 Billion | 51.42 Billion | 11.58 Billion | -3.75 Billion |
| Investing Cash Flow | 1.81 Billion | 2.85 Billion | 225.27 Billion | -2.41 Billion | 145.45 Billion | 33.64 Billion |
| Investments in PPE | -329.01 Million | -346.92 Million | -3.24 Billion | -896.19 Million | -646.94 Million | -810.05 Million |
| Acquisitions | - | - | 31.04 Billion | 1.00 | 31.04 Billion | -8.17 Million |
| Investment purchases | -556.6 Million | -1.43 Billion | -106.41 Billion | -214.00 | -60 Billion | -15.84 Billion |
| Sales/Maturities of investments | 1.5 Billion | 4.71 Billion | 305 Billion | -1.00 | 175 Billion | 50 Billion |
| Other Investing Activities | 2.14 Billion | -80.67 Million | -1.1 Billion | -1.51 Billion | 60.14 Million | 308.6 Million |
| Financing Cash Flow | -1.06 Billion | 23.68 Billion | 6.62 Billion | -9.88 Billion | 19.21 Billion | -1.36 Billion |
| Debt repayment | -26.06 Billion | -25 Billion | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 25 Billion | - | 6.62 Billion | -9.88 Billion | 19.21 Billion | -1.36 Billion |
| Accounts receivables | -15.08 Billion | 103.22 Million | -53.57 Billion | -31.31 Billion | -12.35 Billion | -11.61 Billion |
| Accounts payables | 4.78 Billion | 10.21 Billion | -20.71 Billion | -322.68 Million | -8.01 Billion | -3.05 Billion |
| Inventory | -17.73 Billion | -6.41 Billion | -13.7 Billion | 4.52 Billion | 391.54 Million | -4.79 Billion |
| Other working capital | -13.89 Billion | -287.99 Million | 10.73 Billion | -17.77 Billion | 18.83 Billion | 15.74 Billion |
| Cash at beginning of period | 289.5 Billion | 239.7 Billion | 104.05 Billion | 271.39 Billion | 106.44 Billion | 103.57 Billion |
| Cash at end of period | 284.86 Billion | 289.5 Billion | 239.7 Billion | 239.7 Billion | 271.39 Billion | 106.44 Billion |
| Capital Expenditure | -329.01 Million | -346.92 Million | -3.24 Billion | -896.19 Million | -646.94 Million | -810.05 Million |
| Effect of forex changes on cash | 1.43 Billion | 848.55 Million | -2.05 Billion | -1.08 Billion | 4.3 Billion | -2.09 Billion |
| Net cash flow / Change in cash | -4.64 Billion | 49.8 Billion | 135.64 Billion | -31.69 Billion | 164.94 Billion | 2.86 Billion |
| Free Cash Flow | -7.15 Billion | 20.02 Billion | -99.07 Billion | -19.2 Billion | -4.67 Billion | -28.13 Billion |
VTOL
CRE
1587
601099
214330
GGAMF